Loading chat...

MA S1711

Bill

Status

Introduced

2/27/2025

Primary Sponsor

John Keenan

Click for details

Origin

Senate

194th General Court

AI Summary

  • All state and county correctional facilities must offer FDA-approved medication for addiction treatment (MAT) to detained, committed, or incarcerated persons upon recommendation of a qualified addiction specialist, with assessments required within 24 hours of admission

  • Incarcerated individuals already receiving MAT prior to custody must continue receiving the same medication and dosage within 24 hours unless clinically contraindicated; positive drug screenings cannot be used to deny treatment or impose disciplinary infractions

  • Re-entry treatment plans must be established at least 120 days before discharge (or 30 days minimum for shorter sentences), including referrals to community providers, at least 2 doses of an opioid antagonist, and assistance with MassHealth enrollment

  • Facilities are prohibited from using incentives, rewards, or punishments to influence an individual's decision to accept or decline addiction treatment

  • Correctional facilities must submit semi-annual reports to the Department of Public Health and legislative committees tracking MAT utilization, overdoses, treatment continuity, and post-release outcomes

Legislative Description

Regarding consistent care for addiction rooted in evidence

Last Action

Accompanied a study order, see S2972

2/26/2026

Committee Referrals

Health Care Financing1/22/2026
Public Safety and Homeland Security2/27/2025

Full Bill Text

No bill text available